Tumor Recurrence in Hepatocellular Carcinoma Patients after Radiofrequency Ablation: Portal Hypertension as an Indicator of Recurrence of Hepatocellular Carcinoma
Authors:
Open Access
- 1 January 2018
- journal article
- Published by The Korean Society of Radiology in Journal of the Korean Society of Radiology
- Vol. 79 (5) , 264-270
Abstract
Jang SW, et al. J Korean Soc Radiol. 2018 Nov;79(5):264-270. https://doi.org/10.3348/jksr.2018.79.5.264Keywords
This publication has 30 references indexed in Scilit:
- Portal hypertension is associated with poor outcome of transarterial chemoembolization in patients with hepatocellular carcinomaEuropean Radiology, 2017
- p38α Inhibits Liver Fibrogenesis and Consequent Hepatocarcinogenesis by Curtailing Accumulation of Reactive Oxygen SpeciesCancer Research, 2013
- EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinomaJournal of Hepatology, 2012
- Radiofrequency Ablation for Hepatocellular Carcinoma: 10-Year Outcome and Prognostic FactorsAmerican Journal of Gastroenterology, 2012
- Radiofrequency Ablation versus Hepatic Resection for the Treatment of Hepatocellular Carcinomas 2 cm or Smaller: A Retrospective Comparative StudyRadiology, 2012
- Management of Hepatocellular Carcinoma: An Update ΔσHepatology, 2011
- Noninvasive assessment of portal hypertension in patients with cirrhosisHepatology, 2011
- Hepatic venous pressure gradient can predict the development of hepatocellular carcinoma and hyponatremia in decompensated alcoholic cirrhosisEuropean Journal of Gastroenterology & Hepatology, 2009
- Hepatitis B: Liver fibrosis and hepatocellular carcinomaGastroentérologie Clinique Et Biologique, 2009
- Rising Incidence of Hepatocellular Carcinoma in the United StatesNew England Journal of Medicine, 1999